The Pink Sheet
“The Pink Sheet” offers detailed insights into the prescription pharmaceutical sector. Often referred to as "The Bible" of the industry, this publication tracks important regulatory actions from the FDA, FTC, and CMS, as well as developments in Congress. It also reports on industry happenings, including mergers and acquisitions, new product launches, and leadership changes. Additionally, it provides financial updates on company sales and earnings, as well as stock performance. Its thorough coverage is essential for effective business development and commercialization strategies that enhance profitability.
Outlet metrics
Global
N/A
Country
N/A
Category
N/A
Articles
-
Mar 27, 2024 |
pink.pharmaintelligence.informa.com | Ian Schofield
Interviews Executive Summary Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.
-
Mar 26, 2024 |
pink.pharmaintelligence.informa.com | Ian Schofield
News Executive Summary The EU’s pharmacovigilance committee says that a review of the available evidence showed that in several cases, blood levels of immunosuppressants increased rapidly to toxic levels in patients who were taking the Pfizer drug. You may also be interested in... Existing Subscriber? Sign in to continue reading. New to Pink Sheet? Start a free trial today!
-
Mar 25, 2024 |
pink.pharmaintelligence.informa.com | Derrick Gingery
News Executive Summary The group will coordinate quantitative medicine issues throughout the FDA's Center for Drug Evaluation and Research to help streamline drug development. You may also be interested in... Existing Subscriber? Sign in to continue reading. New to Pink Sheet? Start a free trial today!
-
Mar 22, 2024 |
pink.pharmaintelligence.informa.com | Ian Schofield
News Executive Summary Law firm Sidley Austin says the net overall effect of the pharmaceutical package on innovation and investment is “uncertain at best.” You may also be interested in... Existing Subscriber? Sign in to continue reading. New to Pink Sheet? Start a free trial today!
-
Mar 21, 2024 |
pink.pharmaintelligence.informa.com | Kate Rawson
Analysis Executive Summary As FDA is readying to go back to in-person advisory committee meetings this fall, the centers have different ideas about how to use their expert panels. You may also be interested in... Existing Subscriber? Sign in to continue reading. New to Pink Sheet? Start a free trial today!
The Pink Sheet journalists
Alexandra Shimmings
Andrea Charles
Anju Ghangurde
Bowman Cox
Brenda Sandburg
Brian Yang
Bridget Silverman
Cathy Kelly
Denise Peterson
Derrick Gingery
Dexter Yan
Eliza Slawther
Francesca Bruce
Ian Haydock
Ian Schofield
Joseph Haas
Lisa Takagi
M. Nielsen Hobbs
Mandy Jackson
Neena Brizmohun
Ramsey Baghdadi
Sarah Karlin-Smith
Sue Sutter
Vibha Ravi
Vibha Sharma
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
https://pink.citeline.com/Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →